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Background/Introduction 
Innovative and feasible ways to encourage physical activity (PA) in diabetic patients are needed. 
We aimed to evaluate a new interdisciplinary program encouraging health professionals in the 
community to establish community-based PA programs for patients with type 2 diabetes.  
 
Methods 
The one day interdisciplinary education program took place in the French part of Switzerland in 
November 2010 and included theoretical presentations, therapeutic education skills training, 
practical PA sessions, interactive discussions with diabetic patients participating in ongoing PA 
programs and profession-specific workshops. All participants were given a 47-item evaluation form 
including both closed and open questions.  
 
Results 
Seventy-one health professional participated (23 physicians, 18 dieticians, 16 sport therapists and 
14 diabetes educators) and all filled out the evaluation form.  Ninety-three % or more of the 
participants stated that such an education program was innovative and found it to be adapted or 
very adapted to their daily practice. Ninety-three % or more found all above mentioned aspects of 
the program both interesting or very interesting and helpful or very helpful for their daily practice 
with the exception of therapeutic education which was helpful or very helpful for 86% of the 
participants.  Fifty-five % of the participants rated the theoretical presentations, 49% the 
therapeutic education sessions, 51% the practical PA sessions, 71% the discussion with patients 
and 43% the profession-specific workshops as being very interesting. They were no gender or 
health profession-specific differences in the evaluation (all p=NS). In response to the open 
question “what is your general impression of this education program”, 33/37 responses mentioned 
the interdisciplinary nature to be an innovative and outstanding strength of the program.  
 
Conclusion 
This innovative interdisciplinary education program was equally attractive across different health 
professions working in the community. The perceived outstanding strengths were the 
interdisciplinary nature and the discussion with patients.  Further novel approaches of training 
programs and their effects on modifying patient behavior will be evaluated in the future.  
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Background/Introduction 
Several fitness outcomes such as muscular strength, aerobic fitness or walking speed are 
important predictors of mortality and morbidity. We tested if different physical fitness measures 
correlated to classical morbidity and mortality outcome measures such as BMI, cardiovascular risk 
factors, metabolic control, diabetic complications and socioeconomic status in patients with type 2 
diabetes.  
 
Methods 
Seventy-seven patients from 8 DIAfit centers in the French part of Switzerland were recruited to 
participate in the study. Hypoglycemic episodes, medication use, BMI, blood pressure, vibration 
threshold (a measure of neuropathy), lipid profile and HbA1c  were assessed. Educational level 
(EL) was used as proxy for socioeconomic status. We tested the following fitness outcomes: 
Aerobic fitness (maximal cycle ergometry; W), walking speed (required time for 10m walk; sec), 
functional lower limb muscle strength (required time for chair stand; sec), balance (maximal time 
for unipedal stand; sec) and flexibility (finger-floor distance; cm).   
 
Results 
All seventy-seven patients (age 60.2 ± 10.3 yrs (range 30-85 yrs), 58% female, diabetes duration 
9.3 ± 7.2 yrs) participated in the study. 6% had at at least weekly hypoglycemic episodes. 77% had 
treated hypertension, 62% had treated dyslipidemia. For 3 patients, falls have been recorded in the 
last year. The BMI was 31.8 ± 4.9 kg/m2, the vibration score 5.5 ± 1.9 and the HbA1c 7.3 ± 1.7%. 
41% of the participants had a high, 37% a middle and 22% alow EL). Among all 5 fitness 
measures, age was inversely correlated with aerobic fitness and balance (r= -0.3, p=0.02 and -0.4, 
p=0.001). Furthermore, aerobic fitness was higher in men compared to women P=0.0001). In this 
population, BMI, the vibration threshold, HbA1c levels, the presence of hypertension or of 
dyslipidemia were not associated with physical fitness measures except for a positive correlation 
between the vibration sensibility and balance (r=0.3, p=0.04). In contrast, EL was associated with 
aerobic fitness (r=0.48, p=0.001), muscular strength (-0.4, p=0.006) and walking speed (-0.47,  
p=0.001).  
 
Conclusion 
In this population of mostly treated patients with type 2 diabetes, classical morbidity and mortality 
outcome measures were not associated with different physical fitness measures. In contrast, 
socioeconomic status was highly associated with physical fitness measures in these patients. 
These findings provide insight into different modulable clinical pathways with the perspective to 
further improve outcomes.  
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Background and aims 
Sugar-sweetened beverages (SSB) have unfavorable effects on glucose and lipid metabolism if 
consumed in high quantities by obese subjects but the effect of lower doses in normal weight 
subjects is less clear. The aim was to investigate the effects of SSB, consumed in small to 
moderate quantities for three weeks on LDL particle distribution, acylcarnitine profiles and other 
parameters of glucose and lipid metabolism in healthy young men.  
 
Materials and Methods 
29 subjects were studied in a prospective, randomized, controlled cross-over trial. Six three-week 
interventions were assigned in random order: (1-5) 600 ml SSB containing 40 or 80 g of fructose 
(medium/high fructose (MF/HF)), or glucose/day (medium/high glucose (MG/HG)) or 80 g of 
sucrose/day (high sucrose (HS)); (6) dietary advice to consume low amounts of fructose (LF). 
Outcome parameters were measured at baseline and after each intervention. In addition, 
acylcarnitine profiles (fasting and during an euglycemic hyperinsulinemic clamp) were measured by 
mass spectroscopy in a second group of 9 subjects undergoing the same interventions.  
 
Results 
LDL-particle size was reduced after HF by -0.51nm (95% CI -0.19 to -0.82nm) and after HS by -
0.43nm (-0.12 to -0.74, p<0.05 for both). Similarly, a more atherogenic LDL subclass distribution 
was seen when fructose containing SSB were consumed (MF, HF and HS, p<0.05). Fasting 
glucose increased significantly after all interventions (4-9%, p<0.05). Long-chain fasting 
acylcarnitines were increased after fructose and sucrose diets (HF and HS), but not after glucose 
(HG) diets (e.g. C16 Palmitoylcarnitine HF 1.36, HS 1.34 vs HG 0.96 µmol/l, p < 0.05). Depending 
on the diet, an euglycemic hyperinsulinemic clamp has differential effects on the levels of long 
chain (i.e. intermediates prior to beta-oxidation) versus short and medium chain acylcarnitines. 
Overall, these acylcarnitine patterns suggest an effect of fructose containing diets on beta-
oxidation flux. 
 
Conclusion 
The present data clearly demonstrate potentially harmful effects of low to moderate consumption of 
SSB on markers of cardiovascular risk such as LDL particles and fasting glucose. Analysis of 
acylcarnitine profiles is performed for the first time in this setting and yields further insights into 
fatty acid metabolism, suggesting effects of fructose containing diets on beta-oxidation of fatty 
acids. 
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Background/Introduction 
Subclinical thyroid dysfunction has been associated with systolic and diastolic dysfunction. 
However, few prospective data exist regarding the association between subclinical thyroid 
dysfunction and heart failure (HF) events, as well as subgroups at increased risk. 
 
Methods 
We conducted a systematic review in MEDLINE and EMBASE databases without language 
restrictions, and included prospective observational cohorts with a baseline thyroid function 
measurement and subsequent follow-up of HF events. Individual data on 19’726 participants with 
198'725 person-years of follow-up were supplied from 5 prospective cohorts in the United States 
and Europe. Euthyroidism was defined as a TSH 0.45-4.49 mIU/L, subclinical hypothyroidism as a 
TSH between 4.5-19.9 mIU/L and subclinical hyperthyroidism as a TSH <0.45 mIU/L, both with 
normal free thyroxine levels. 
 
Results 
Among 19'726 participants, 1’618 had subclinical hypothyroidism (8.2%), 515 subclinical 
hyperthyroidism (2.6%) and 17'593 were euthyroid. During follow-up, 1'838 participants had HF 
events. In age- and gender-adjusted analyses, the risk of HF increased with higher TSH levels: 
hazard ratio (HR) was 1.04 (95% confidence interval [CI] 0.79-1.36) for a TSH level of 4.5-6.9 
mIU/L, 1.81 (CI 0.88-3.71) for a TSH level of 7.0 to 9.9 mIU/L, and 1.93 (CI 1.07-3.48) for a TSH 
level of 10.0 to 19.9 mIU/L (p for trend = 0.01). After further adjustment for cardiovascular risk 
factors, risk of HF was lower but remained significant among those with TSH ≥10 mIU/L (HR 1.55, 
CI 1.08-2.21). HR among those with TSH ≥10 mIU/L was higher (HR 2.14, CI 1.15-3.97) in 
sensitivity analyses excluding thyroid medication users. 
 
Conclusion 
Subclinical hypothyroidism, but not subclinical hyperthyroidism, is associated with an increased 
risk of HF events in those with higher TSH levels, particularly in those with TSH levels ≥10 mIU/L. 
Given the high prevalence of subclinical hypothyroidism and of HF events among elderly, this 
question needs to be addressed in an appropriately powered randomized controlled trial.  
 
 
Schweizerische Gesellschaft für 
Endokrinologie und Diabetologie - SGED
Société Suisse d‘Endocrinologie
et de Diabétologie - SSED
Jahresversammlung
Assemblée annuelle
1. und 2. Dezember 2011
le 1er et 2 décembre 2011
Inselspital Bern
2011
1Contents
    page
Program of the Annual Meeting SGED-SSED   4
Program of the Scientific Meeting ASEMO-SAMO   6
Oral presentations «Metabolism» – Session 1   8
Oral presentations «Pituitary and ...» – Session 2   8
Oral presentations «Miscellaneous clinical» – Session 3   9
Oral presentations «Beta-cell and ...» – Session 4   10
Poster presentations   11
Abstracts 14 – 29
Traktanden GV / Ordre du jour   30
Galadinner   33
Sponsoren / Contributeurs   33
Plenaries, oral presentations (Ettore Rossi, Kursraum 1), 
industrial exhibition, lunch/coffee, posters
Langhans Auditorium (Pathology), 
oral presentations
Kontaktadresse:
Schweizerische Gesellschaft für
Endokrinologie und Diabetologie
Rütistrasse 3a
CH-5400 Baden
Tel. 056 200 17 50, Fax 056 200 17 95
office@sgedssed.ch, www.sgedssed.ch
